I agree totally with your assessment. It's criminal that this leech is getting away with it? Not only is he stupid (in terms of the biotech industry), he is exceptionally greedy with it.

How can one start a change of chairman of the board at the next shareholder meeting? Is there any board or forum that can assess the performance of a board ensuring that the shareholders can effectively gauge the board members?

I am convinced Maxygen technology platform i the way to go in generating next generation therapeutic proteins, it's a pity that it has never had the direction to put a drug on the market. The closest one will be "MaxyVII" which will earn Bayer significant amount of money in the Hemophilia and trauma markets.